{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:00:56Z","timestamp":1790809256226,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jtct.2025.05.017","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T11:06:47Z","timestamp":1748084807000},"page":"588.e1-588.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Feasibility of a Total Body Irradiation-Augmented Reduced-Toxicity Conditioning Regimen with an Antithymocyte Globulin\/Post-Transplantation Cyclophosphamide Combination for Haploidentical Donor Transplantation in Adult Acute Lymphoblastic Leukemia"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1266-9353","authenticated-orcid":false,"given":"Jaehyun","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daehun","family":"Kwag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi June","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9810-2050","authenticated-orcid":false,"given":"Sung-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Sik","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Seong","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6653-2956","authenticated-orcid":false,"given":"Yoo-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Je","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-9131","authenticated-orcid":false,"given":"Jae-Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2025.05.017_bib0001","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2025.05.017_bib0002","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/bloodadvances.2021004916","article-title":"Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia","volume":"6","author":"Wieduwilt","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.05.017_bib0003","article-title":"Comparison of long-term outcomes of double unit cord blood versus haploidentical donor transplantation in adult patients with acute lymphoblastic leukemia regarding KIR-ligand mismatch","volume":"25","author":"Lee","year":"2025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jtct.2025.05.017_bib0004","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41409-020-0803-y","article-title":"Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients","volume":"55","author":"Spyridonidis","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.017_bib0005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41409-024-02363-7","article-title":"Comparative analysis of reduced toxicity conditioning regimens between fludarabine plus melphalan and fludarabine plus busulfex in adult patients with acute lymphoblastic leukemia","volume":"59","author":"Ahn","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.017_bib0006","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3324\/haematol.2015.132860","article-title":"Nonmyeloablative allogeneic hematopoietic cell transplantation","volume":"101","author":"Storb","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2025.05.017_bib0007","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3324\/haematol.2020.247296","article-title":"Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia","volume":"106","author":"Nagler","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2025.05.017_bib0008","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1016\/S2352-3026(22)00036-9","article-title":"In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial","volume":"9","author":"Marks","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2025.05.017_bib0009","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41409-020-01101-z","article-title":"Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia","volume":"56","author":"Greil","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.017_bib0010","doi-asserted-by":"crossref","first-page":"32.e1","DOI":"10.1016\/j.jtct.2024.07.017","article-title":"Combination of anti-thymocyte globulin with post-transplant cyclophosphamide for GVHD prophylaxis in patients undergoing haploidentical hematopoietic stem cell transplantation: systematic review and meta-analysis","volume":"31","author":"Luo","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.05.017_bib0011","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1182\/bloodadvances.2024014879","article-title":"Intermediate-dose post-transplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation","volume":"9","author":"Hyder","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.05.017_bib0012","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/cncr.30180","article-title":"Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation","volume":"122","author":"Gaballa","year":"2016","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.jtct.2025.05.017_bib0013","article-title":"Fludarabine-melphalan with total body irradiation or with thiotepa conditioning for adult patients with acute lymphoblastic leukemia receiving allogeneic stem cell transplantation","volume":"144","author":"Chumnumsiriwath","year":"2024","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.jtct.2025.05.017_bib0014","article-title":"Feasibility of TBI-augmented reduced toxicity conditioning regimen with ATG\/Ptcy combination for haploidentical donor transplantation in adult acute lymphoblastic leukemia","volume":"144","author":"Ahn","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.05.017_bib0015","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/ajh.23465","article-title":"Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission","volume":"88","author":"Eom","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2025.05.017_bib0016","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/leu.2012.164","article-title":"Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"26","author":"Lee","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2025.05.017_bib0017","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/cncr.31874","article-title":"Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia","volume":"125","author":"Yoon","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2025.05.017_bib0018","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/annonc\/mdw123","article-title":"Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"27","author":"Yoon","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtct.2025.05.017_bib0019","doi-asserted-by":"crossref","DOI":"10.1177\/20406207231154713","article-title":"Superior survival outcome of blinatumomab compared with conventional chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: a propensity score-matched cohort analysis","volume":"14","author":"Yoon","year":"2023","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.jtct.2025.05.017_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cca.2018.10.037","article-title":"Considerations for monitoring minimal residual disease using immunoglobulin clonality in patients with precursor B-cell lymphoblastic leukemia","volume":"488","author":"Jo","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jtct.2025.05.017_bib0021","doi-asserted-by":"crossref","first-page":"563","DOI":"10.6004\/jnccn.2024.0051","article-title":"Acute lymphoblastic leukemia, version 2.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Shah","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtct.2025.05.017_bib0022","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41409-020-01097-6","article-title":"Impact of donor type on long-term graft-versus-host disease-free\/relapse-free survival for adult acute lymphoblastic leukemia in first remission","volume":"56","author":"Yoon","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.017_bib0023","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.05.017_bib0024","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtct.2025.05.017_bib0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41577-020-00457-z","article-title":"T cell regeneration after immunological injury","volume":"21","author":"Velardi","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtct.2025.05.017_bib0026","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.017_bib0027","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2011.110","article-title":"The EBMT risk score","volume":"47","author":"Gratwohl","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.017_bib0028","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41409-023-02139-5","article-title":"Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation","volume":"59","author":"Spyridonidis","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.017_bib0029","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbmt.2017.11.013","article-title":"Augmenting total body irradiation with a cranial boost before stem cell transplantation protects against post-transplant central nervous system relapse in acute lymphoblastic leukemia","volume":"24","author":"Gao","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.017_bib0030","doi-asserted-by":"crossref","first-page":"171.e1","DOI":"10.1016\/j.jtct.2020.10.008","article-title":"Improved outcomes of haploidentical hematopoietic cell transplantation with total body irradiation-based myeloablative conditioning in acute lymphoblastic leukemia","volume":"27","author":"Dholaria","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.05.017_bib0031","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41409-021-01550-0","volume":"57","author":"Swoboda","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.017_bib0032","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/bloodadvances.2020003005","article-title":"Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide","volume":"5","author":"Rambaldi","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.05.017_bib0033","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41409-023-02085-2","article-title":"Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation","volume":"58","author":"Dul\u00e9ry","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.017_bib0034","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1615\/CritRevImmunol.2016017507","article-title":"Immunostimulatory effects of melphalan and usefulness in adoptive cell therapy with antitumor CD4+ T Cells","volume":"36","author":"Kuczma","year":"2016","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jtct.2025.05.017_bib0035","doi-asserted-by":"crossref","first-page":"695.e1","DOI":"10.1016\/j.jtct.2022.07.021","article-title":"Post-transplantation cyclophosphamide versus tacrolimus and methotrexate graft-versus-host disease prophylaxis for HLA-matched donor transplantation","volume":"28","author":"Mehta","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.05.017_bib0036","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2025.05.017_bib0037","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbmt.2016.11.008","article-title":"Haploidentical transplantation with post-transplantation cyclophosphamide for high-risk acute lymphoblastic leukemia","volume":"23","author":"Srour","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.017_bib0038","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/cncr.33522","article-title":"Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"127","author":"Nagler","year":"2021","journal-title":"Cancer"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725011996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725011996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:45:08Z","timestamp":1785548708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725011996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2666636725011996"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.05.017","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of a Total Body Irradiation-Augmented Reduced-Toxicity Conditioning Regimen with an Antithymocyte Globulin\/Post-Transplantation Cyclophosphamide Combination for Haploidentical Donor Transplantation in Adult Acute Lymphoblastic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}